References
- Ander BP, Dupasquier CM, Prociuk MA, Pierce GN. 2003. Polyunsaturated fatty acids and their effects on cardiovascular disease. Exp Clin Cardiol. 8:164–172.
- Barber RD, Harmer DW, Coleman RA, Clark BJ. 2005. GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genomics. 21:389–395.
- Bonow RO, Smaha LA, Smith SCJr, Mensah GA, Lenfant C. 2002. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation. 106:1602–1605.
- Bordoni A, Di Nunzio M, Danesi F, Biagi PL. 2006. Polyunsaturated fatty acids: from diet to binding to ppars and other nuclear receptors. Genes Nutr. 1:95–106.
- Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, The M, . 2009. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 55:611–622.
- Das UN. 2000. Beneficial effect(s) of n − 3 fatty acids in cardiovascular diseases: but, why and how?. Prostaglandins Leukot Essent Fatty Acids. 63:351–362.
- Deckelbaum RJ, Worgall TS, Seo T. 2006. n − 3 fatty acids and gene expression. Am J Clin Nutr. 83:1520S–1525S.
- Devika PT, Stanely Mainzen Prince P. 2009. Preventive effect of ( − )epigallocatechin gallate on lipids, lipoproteins, and enzymes of lipid metabolism in isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol. 23:387–393.
- Di Nunzio M, van Deursen D, Verhoeven AJ, Bordoni A. 2010. n − 3 and n − 6 Polyunsaturated fatty acids suppress sterol regulatory element binding protein activity and increase flow of non-esterified cholesterol in HepG2 cells. Br J Nutr. 103:161–167.
- Gabbiani G, Kocher O, Bloom WS, Vandekerckhove J, Weber K. 1984. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J Clin Invest. 73:148–152.
- Goto T, Saito Y, Morikawa K, Kanamaru Y, Nagaoka S. 2012. Epigallocatechin gallate changes mRNA expression level of genes involved in cholesterol metabolism in hepatocytes. Br J Nutr. 107:769–773.
- Goya LMM, Ramos S, Mateos R, Bravo L. 2009. A cell culture model for the assessment of the chemopreventive potential of dietary compounds. Curr Nutr Food Sci. 5:56–64.
- Harris WS, Kris-Etherton PM, Harris KA. 2008. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep. 10:503–509.
- Hennig EE, Mikula M, Orlowska J, Jarosz D, Bielasik A, Regula J, Ostrowski J. 2008. Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett's esophagus. J Mol Med. 86:233–242.
- Kitajima S, Sakuma S, Morimoto M. 1998. Macroscopic distribution of coronary atherosclerotic lesions in cholesterol-fed rabbits. Exp Anim. 47:221–227.
- Kuriyama S. 2008. The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies. J Nutr. 138:1548S–1553S.
- Luczaj W, Zapora E, Szczepanski M, Wnuczko K, Skrzydlewska E. 2009. Polyphenols action against oxidative stress formation in endothelial cells. Acta Pol Pharm. 66:617–624.
- Martini C, Pallottini V, De Marinis E, Marino M, Cavallini G, Donati A, . 2008. Omega-3 as well as caloric restriction prevent the age-related modifications of cholesterol metabolism. Mech Ageing Dev. 129:722–727.
- Mullen A, Loscher CE, Roche HM. 2010. Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages. J Nutr Biochem. 21:444–450.
- Ocana E, Bohorquez JC, Perez-Requena J, Brieva JA, Rodriguez C. 2003. Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. Atherosclerosis. 170:39–48.
- Ridker PM, Silvertown JD. 2008. Inflammation, C-reactive protein, and atherothrombosis. J Periodontol. 79:1544–1551.
- Riediger ND, Othman RA, Suh M, Moghadasian MH. 2009. A systemic review of the roles of n − 3 fatty acids in health and disease. J Am Diet Assoc. 109:668–679.
- Sarig S, Utian WH, Sheean LA, Gorodeski GI. 1995. Distribution of unesterified cholesterol-containing particles in human atherosclerotic lesions. Am J Pathol. 146:139–147.
- Suzuki J, Isobe M, Morishita R, Nagai R. 2009. Tea polyphenols regulate key mediators on inflammatory cardiovascular diseases. Mediators Inflamm. 2009:494928.
- Tipoe GL, Leung TM, Hung MW, Fung ML. 2007. Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets. 7:135–144.
- Toth PP, Dayspring TD, Pokrywka GS. 2009. Drug therapy for hypertriglyceridemia: fibrates and omega-3 fatty acids. Curr Atheroscler Rep. 11:71–79.
- Trogan E, Choudhury RP, Dansky HM, Rong JX, Breslow JL, Fisher EA. 2002. Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice. Proc Natl Acad Sci USA. 99:2234–2239.